Hedge fund SAC Capital Advisors LP is being investigated by federal regulators for using inside information to profit from a health care takeover in 2009, the Wall Street Journal reported.
Amgen Inc., the world's largest biotech company by revenue, likely will focus on sales prospects for its top drugs and progress on its experimental drugs when it reports third-quarter results.
The European Union is investigating whether drug companies Novartis and Johnson & Johnson colluded to keep a generic painkiller out of the Dutch market, the bloc's antitrust watchdog said.
Starting HIV therapy in patients with both HIV and tuberculosis within two weeks of TB treatment increases survival by 33%.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced that the U.S. Food and Drug Administration has approved a new use for Byetta (exenatide) injection.
Drugmaker Bristol-Myers Squibb Co. said that its commercial operations senior vice president, Anthony C. Hooper, has left the company.
A review of the genetic and biochemical abnormalities associated with autism reveals a possible link between the widely diagnosed neurological disorder and Type 2 diabetes.
Ipsen and Syntaxin announced a global strategic collaboration to explore the discovery and development of new compounds in the field of botulinum toxins.
Synergy Health announced the appointment of Steve Poynter as business development manager.
Bristol-Myers Squibb announced a series of changes within its senior management team.
LabLogic Systems is launching Version 6 of its Debra LIMS for drug metabolism studies. This version makes provision for new ways of working in pharmaceutical research and rationalizes complexities.
Sartorius Stedim Biotech has expanded its range of Flexel products and now offers 1,500 L and 2,000 L volumes, as well as scalable, ready-to-use mixing technology to enhance process flexibility in biomanufacturing and optimize manufacturing costs.
Ricerca Biosciences has announced a partnership agreement with Dr. Jeanne Stadler, a well-known consultant who specializes in reproductive and developmental toxicology.
A new paper reports the synthesis and testing of a family of potential antimicrobial molecules and finds that their therapeutic effect is comparable to that of many currently used antimicrobial agents.
Regulus Therapeutics Inc. and collaborators announced the publication of new data showing the first demonstration of marked increases in high density lipoprotein cholesterol, and suppression of plasma triglyceride levels.